Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2021 / Article

Research Article | Open Access

Volume 2021 |Article ID 5510099 | https://doi.org/10.1155/2021/5510099

Babita Aryal, Purushottam Niraula, Karan Khadayat, Bikash Adhikari, Dadhiram Khatri Chhetri, Basanta Kumar Sapkota, Bibek Raj Bhattarai, Niraj Aryal, Niranjan Parajuli, "Antidiabetic, Antimicrobial, and Molecular Profiling of Selected Medicinal Plants", Evidence-Based Complementary and Alternative Medicine, vol. 2021, Article ID 5510099, 15 pages, 2021. https://doi.org/10.1155/2021/5510099

Antidiabetic, Antimicrobial, and Molecular Profiling of Selected Medicinal Plants

Academic Editor: Riaz Ullah
Received23 Feb 2021
Accepted13 Apr 2021
Published07 May 2021

Abstract

Natural products have been the center of attraction ever since they were discovered. Among them, plant-based natural products were popular as analgesics, anti-inflammatory, antidiabetic, and cosmetics and possess widespread biotechnological applications. The use of plant products as cosmetics and therapeutics is deep-rooted in Nepalese society. Although there are few ethnobotanical studies conducted, extensive research of these valuable medicinal plants has not been a priority due to the limitation of technology and infrastructure. Here, we selected 4 traditionally used medicinal plants to examine their bioactive properties and their enzyme inhibition potential. α-Glucosidase and α-amylase inhibitory activities were investigated using an in vitro model followed up by antioxidant and antimicrobial activities. The present study shows that ethyl acetate fraction of Melastoma melabathrium (IC50 9.1 ± 0.3 µg/mL) and water fraction Acacia catechu (IC50 9.0 ± 0.6 µg/mL) exhibit strong α-glucosidase inhibition. Likewise, the highest α-amylase inhibition was shown by crude extracts of Ficus religiosa (IC50 29.2 ± 1.2 µg/mL) and ethyl acetate fractions of Shorea robusta (IC50 69.3 ± 1.1 µg/mL), and the highest radical scavenging activity was shown by F. religiosa with an IC50 67.4 ± 0.6 µg/mL. Furthermore, to identify the metabolites within the fractions, we employed high-resolution mass spectrometry (LC-HRMS) and annotated 17 known metabolites which justify our assumption on activity. Of 4 medicinal plants examined, ethyl acetate fraction of S. robusta, ethyl acetate fraction of M. melabathrium, and water or ethyl acetate fraction of A. catechu extracts illustrated the best activities. With our study, we set up a foundation that provides authentic evidence to the community for use of these traditional plants. The annotated metabolites in this study support earlier experimental evidence towards the inhibition of enzymes. Further study is necessary to explore the clinical efficacy of these secondary molecules, which might be alternatives for the treatment of diabetes and pathogens.

1. Background

Natural products have gained significant appreciation as an alternative and/or complementary healthcare approach with extensive pharmaceutical and biological properties [1, 2]. Worldwide, more than 900 medicinal plants are used for the cure of diabetes by different traditional practices like Ayurveda, Homeopathy, Amchi, Unani, Sidha, Chinese medicine, and folklore [3]. Although a very small number of plants are investigated for the treatment of pathogens, it is found more effective than synthetic drugs [4]. Diversities of secondary metabolites in plants are affected by various factors such as climate, harvest time, storage conditions, genetics, and variability [5].

In Nepal, more than 700 plant species constitute medicinal properties. They are used by different ethnic communities as a local source of medicine mostly called Ayurveda or Homeopathy [6]. As Nepal is climatically diverse, medicinal plants have massive attention among researchers for metabolic enzyme inhibition for the cure of infectious diseases. Proper understanding of traditional knowledge and research over them using more scientific methods might lead to the subsequent treatment of multiple diseases [7]. Diabetes and pathogens are postulated to have a high risk of emergence in Southeast Asia (SEA) [8, 9]. Because of diabetes, 1.2 million people died in SEA in 2019 [8]. The death rate of people dying with infectious diseases is very high [9]. Medicinal plants possess immune-modulatory and antioxidant properties, leading to antibacterial activities. They are known to have versatile immune-modulatory activities by stimulating both nonspecific and specific immunity [10]. Phytochemicals such as vitamins (A, C, E, and K), carotenoids, terpenoids, flavonoids, polyphenols, alkaloids, tannins, saponins, pigments, enzymes, and minerals have hypercholesterolemic, anti-inflammatory, analgesic, antidiabetic, antimicrobial, antiplaque, antihypertensive, and anthelmintic activities [1114].

The desorption/ionization methods for mass spectrometry had been technologically advanced for chemical identification over the past decades [15]; however, the characterization of plant extract using mass spectrometry is relatively difficult due to the lack of reliable extraction procedures [13, 14, 16]. Quadruple time-of-flight liquid chromatography-mass spectroscopy (Q-TOF LC/MS) technology provides an outstanding separation of major and trivial constituents of natural product extracts along with increasing selectivity and avoiding false-positive findings [17, 18]. This high level of performance allows the elemental composition of each m/z value to be accurately calculated using the software. The high mass resolution of up to 20,000 makes it useful for exact mass measurement as well as for molecular formula generation of any unknown molecule, parent ion, and fragment ion in the plant extracts [19]. This method is rapidly becoming an effective analytical tool to annotate compounds within a short time frame and with high sensitivity. In this study, we prioritized four medicinal plants in Nepal. Along with bioactivity studies, we also characterized/annotated molecules via LC-HRMS. Further purification and characterization of therapeutically novel molecules could be the subject of future work.

2. Materials and Methods

2.1. Chemicals

The α-glucosidase enzyme (CAS No.: 9001-42-7), 4-nitrophenyl α-D-glucopyranoside (CAS No.: 3767-28-0), α-amylase (CAS No.: 9000-90-2), 2-chloro-4-nitrophenyl-α-D-maltotrioside (CAS No.:118291-90-0), acarbose (CAS No.: 56180-94-0), and quercetin (CAS No.: 117-39-5) were purchased from Sigma-Aldrich (Germany). Gallic acid and 2,2-diphenyl-1-picrylhydrazyl (DPPH) were purchased from Molychem (India) and Himedia (India), respectively. Dimethyl sulphoxide, sodium dihydrogen orthophosphate, and other chemicals were purchased from Fisher Scientific (India).

2.2. Collection of Plant Materials

Parts of the plants taken under study were collected based on ethnobotanical and traditional medicinal uses of local healers from different areas of Nepal during May-December 2020. Herbarium specimens were deposited at the Central Department of Botany, Tribhuvan University. The list of medicinal plants selected for the study and their ethnopharmacological applications is shown in Table 1. The plants obtained were air-dried in the shade at room temperature and ground into a fine powder.


Scientific nameFamilyVoucher specimenIndigenous usesChemical constituents

A. catechu (L.F.) wildFabaceaeTUCH-201011It is used for anticancer purposes. It is useful in cold and cough, ulcers, boils, and eruptions of the skin, bleeding piles, antipyretic, acute, and chronic wound healing [2023]. Catechin and taxifolin possess antifungal, antiviral, antibacterial, anti-inflammatory, and antioxidant activity [22].4-Hydroxybenzoic acid, kaempferol, quercetin, 3,4′,7-trihydroxyl-3′,5-dimethoxyflavone, catechin, epicatechin, afzelechin, epiafzelechin, mesquitol, ophioglonin, aromadendrin, phenol [23]; rhamnetin, 4-hydroxyphenol, 3,3′,5,5′,7-pentahydroxyflavane, fisetinidol, 5-hydroxy-2-[2-(4-hydroxyphenyl)acetyl]-3-methoxybenzoic acid,n(2s,3S)-3,7,8,3′,4′-pentahydroxyflavane [24]; rutin [25]; taxifolin [26]; quercetin 3-methyl ether, caryatin, ellagic acid [27]; robinetinidol [28]; gallochin, gossypetin, phlobatannin, quercitin [29]
F. religiosaMoraceaeTUCH-201014Bark is used in diarrhoea, dysentery, anti-inflammatory, antibacterial, cooling, astringent, gonorrhoea, and burns [30, 31]. Leaves are used in hiccups, vomiting, cooling, gonorrhoea, asthma, cough, diarrhoea, and gastric problems. Similarly, fruits are used in fever, tuberculosis, paralysis, asthma, and digestion [3133]. It is used for anticancer activity [34], antioxidant, wound healing and anti- inflammatory activity [35], antidiabetic activity [36], and antiamnesic activity [37]. Lupeol possesses anti-inflammatory activity [38]. Quercetin and kaempferol possess antifungal property [39, 40].Naphthyl-1,3-diol-1-(3β-lanost-5,24-dienyl)-3-n-octadec- 9,12,15-trienoate, naphthyl-1,3-diol-1-(3β-lanostan-19-oic acid-yl)-3- n-octadec-9,12-dienoate, triterpenic ester lanostan-19-oic acid-3β-olyl-n-octadec-9,12,15-trienoate, β-sitosteryl oleate, β-sitosterol glucoside [41]; lupenol, γ-sitosterol, 1,2-Benzenediol [42]; phenol, salicylaldehyde, phenylacetaldehyde, allyl caproate, linalool, n-nonanal, adipoin, methylcyclopentane, 2-dione, itaconic anhydride, 2-phenylethyl alcohol, benzeneacetonitrile, nonadienal, nonen-1-ol, nonadienol, linalool oxide, catechol, coumaran, cinnamyl alcohol, vinylguaiacol, hexenyl tiglate, eugenol, hexenyl hexenoate, β-ionone, dihydroactinidiolide, α-copaene, hexenyl benzoate, eudesmol, eudesmol, epi-α-cadinol, β-eudesmol, α-eudesmol, α-cadinol, pentadecanal, palmitic acid and itaconic anhydride, 3-methylcyclopentane-1, 2-dione [43]; undecane, tridecane, tetradecane, (e)-β-ocimene β-bourbonene, β-caryophyllene, α-trans bergamotene, α-thujene, α-pinene, β-pinene, α-terpinene, limonene, dendrolasine, dendrolasine α-ylangene, α-copaene, aromadendrene, α-humulene, alloaromadendrene, germacrene, bicycle-germacrene, γ-cadinene and δ-cadinene [44, 45]
M. melabathriumMelastomataceaeTUCH-201013It is used in looseness of the bowels, the runs, hemorrhoids, leucorrhoea, wounds and cut lightening urinary issues, leucorrhea, urinary tract, and toothache [46, 47]; antiviral activity, cytotoxicity activity [48], wound healing activity [49], antiulcer activity, antivenom activity [50], antidiabetic activity, antioxidant activity, antihyperlipidemic activity [47]. β-Sitosterol has shown antidiabetic activity [51]. Betulinic acid, quercetin, quercitrin, α-amyrin show anti-inflammatory activity [52].β-Sitosterol, β-sitosterol-3-O-β-D-glucopyranoside, ursolic acid, asiatic acid, 2-hydroxyursolic acid, Kaempferol [53]; α-amyrin, betulinic acid, kaempferol-3-O-β-D-glucoside [54]; 2α-hydroxyursolic acid, β-sitosterol 3-O-β-D-glucopyranoside, 1,2-dilinolenyl-3-O-β-D-galactopyanoside, kaempferol, kaempferol 3-O-α-L-rhamnopyranoside, kaempferol 3-O-β-D-glucopyranoside, kaempferol 3-O-β-D-galactopyranoside, kaempferol 3-O-(2″,6″-di-O-E-p-coumaryl)-β-D-galactopyranoside, quercetin, ellagic acid [55]; gallic acid, benzoic acid, epicatechin, malabathrin, casuarictin [56]
S. robusta gaertnDipterocarpaceaeTUCH-201010It is used in the treatment of ulcer, cough, itching, leprosy, and as anthelmintic [57]. Antibacterial wound healing and anti-inflammatory activity due to the presence of polyphenols, flavonoids, and triterpenoids, etc. Ursolic acid, amyrin extracted from this plant is responsible for showing antibacterial activity and antiulcer [58].Ammarenolic acid, asiatic acid [59]; ursolic acid, tri and tetrahydroxy ursenoic acid, α and β-amyrin, α –amyrenone, mangiferonic acid, benthamic acid and uvaol [58]; bergenin [60]; caryophyllene oxide, calarene epoxide, lupeol, β-humulene, α-amyrin, β-caryophyllene [61]

2.3. Preparation of Crude Extracts and Fractionation

The plant materials were shade-dried and ground into a fine powder. Extraction was done by the cold percolation method. Briefly, the powder of different plants was soaked in methanol for 24 hours at room temperature for three successive days. After 24 hours, the dissolved extracts were filtered through the Whatman-1 filter paper and collected and then concentrated at reduced pressure at 50°C using a rotary evaporator to obtain crude extracts. 50 g of the crude extract was then suspended in distilled water and successively partitioned with three different solvents based on their polarity, i.e., n-hexane, followed by dichloromethane and ethyl acetate.

2.4. Total Phenolic and Flavonoid Contents

The TPC of the extracts was determined using the Folin-Ciocalteu reagent, as described previously [62, 63] with slight modification. 20 μL of each extract (0.5 mg/mL) was separately mixed with Folin-Ciocalteau’s reagent (100 μL, 1 : 10 v/v diluted with distilled water) and aqueous sodium carbonate (Na2CO3, 80 μL, 1 M) solution, and then the mixture was allowed to stand for 15 minutes at room temperature. The reaction mixture's absorbance was measured at 765 nm using a microplate reader (Synergy LX, BioTek, Instruments, Inc., USA). Gallic acid (GA) was used as a standard, and the total polyphenolic concentration in the extracts was expressed as milligrams of gallic acid equivalent per gram of dry weight (mg GAE/g) of the extract. The assay was performed in triplicate.

The TFC of the extracts was determined using the colorimetric method described previously [64, 65] with slight modification. Briefly, 20 μL of each extract (0.5 mg/mL) was separately mixed with 60 μL ethanol and 5 μL aluminium trichloride (AlCl3, 10%). Subsequently, 5 μL of 1 M potassium acetate and 110 μL distilled water were added to each well, and the reaction mixture was allowed to stand for 30 minutes. The absorbance was then measured at 415 nm with a microplate reader against blank. Quercetin was used as standard, and the total flavonoid concentration in the extracts was expressed as milligrams of quercetin equivalent per gram of dry weight (mg QE/g) of extract. For each extract, triplicates of measurements were performed.

2.5. Free Radical Scavenging Activity

The free radical scavenging activity was determined using 2,2-diphenyl-1-picrylhydrazyl (DPPH), as described previously [66]. Briefly, 0.1 mM solution of DPPH in methanol was prepared, and an equal volume (100 μL) of this solution was added to an equal volume of plant samples (100 μL) prepared in 30% DMSO at 0.98–500 μg/mL concentrations. It was incubated in the dark for 30 minutes, and then the absorbance was measured at 517 nm. A 100 μL of 0.1 mM DPPH mixed with 100 μL of 30% DMSO (solvent) was used as control. Quercetin was used as the standard reference compound for this assay. The degree of color change from purple (DPPH radical) to yellow (diphenyl picrylhydrazine) obtained after reduction at different concentrations was measured. The capability to scavenge the DPPH radical was calculated by using the following equation:where Ao is the absorbance of DPPH with 30% DMSO and At is the absorbance of DPPH with a test or reference sample.

2.6. In Vitro α-Glucosidase and α-Amylase Inhibition Assays

The crude extracts for α-glucosidase enzyme inhibitory activity were determined by the method described by Fouotsa et al. with slight modification [67]. The α-glucosidase (0.2 units) was premixed with 500 μg/mL of extract in 100 mM phosphate buffer saline (pH 6.8). Then, 0.7 mM pNPG in the PBS (phosphate buffer saline) buffer was added as a substrate. This reaction mixture was pre-incubated in a 96-well microplate at 37°C for 15 min. The α-glucosidase activity was determined by measuring the p-nitrophenol release from the hydrolysis of pNPG at 405 nm in a microplate with Gene 5 software. Acarbose was used as the standard compound for this assay. The % α-glucosidase inhibitory activity was calculated as given inwhere Ao is the absorbance of enzyme-substrate reaction with 30% DMSO and At is the absorbance of enzyme-substrate with plant extract.

α-Amylase inhibition assay was carried out as described in our previous study [68]. Briefly, 20 µL of plant extracts and 80 µL of porcine pancreas α-amylase (1.5 U/mL) in phosphate buffer of pH 7.0 were loaded in microplate wells, and initial absorbance was taken. The plate was incubated at 37°C for 15 minutes. Then, 100 µL of a substrate (0.5 mM), CNPG3 (in the same buffer), was added to start the reaction with incubation for 15 minutes, and change in absorbance was monitored at 405 nm [68]. The DMSO was taken as control. All the experiments were performed in triplicate in a final volume of 200 μL by using a microplate reader. The % α-amylase inhibitory activity was calculated using equation (2), mentioned earlier.

2.7. Antimicrobial Assay of Plant Extracts

Antimicrobial assay of extracts was performed by the agar well diffusion method in Mueller Hinton Agar (MHA) plates [69]. The test organisms were inoculated in Muller Hinton Broth (MHB) and incubated at 37°C to adjust the turbidity to 0.5 McFarland standards giving a final inoculum of 1.5 × 108 CFU/mL. The MHA plates were lawn-cultured with the above maintained microbial inoculum. Plant extracts of 50 mg/mL concentration were prepared in 50% DMSO. Six wells of 6 mm were bored in the cultured lawn media with the help of a sterile cork-borer (6 mm). Each well was filled with 50 μL plant extract with the positive control (neomycin 50 mg/mL) and negative control (50% DMSO) in each experiment set. It was allowed to diffuse for about 15 minutes at room temperature and incubated for 18–24 hours at 37°C. After incubation, plates were observed to form a clear, i.e., zone of inhibition (ZoI) around the well and measured in mm.

2.8. Determination of MIC and MBC

The broth microdilution method was used to determine the MIC and MBC, according to Clinical and Laboratory Standards Institute (CLSI) [70]. Twofold serial dilutions of extracts were prepared directly in sterile 96-well microdilution plates with flat bottom wells containing MHB to obtain various concentrations. The bacterial inoculum was added at a final concentration of 106 CFU/mL by diluting 1 : 100 the 0.5 McFarland turbidity culture in MHB. Finally, five μL of bacteria was added to each well except for negative control.

Neomycin is a standard drug that was used as a positive control. The plate was covered with a sterile lid and incubated for 24 h at 37°C. Resazurin (0.003%) was added to each well of the microtiter plate and was incubated at 37°C for 3–4 hrs. The wells containing the bacterial growth turned into pink color, whereas the well without bacterial growth remained blue. The MIC was considered as the lowest concentration of the extract that completely inhibits bacterial growth. The MBC was determined by streaking the content of wells onto NA plates with incubation of over 18 hours at 37°C [70].

2.9. Molecular Annotation

Plant fractions were subjected to LC-HRMS. Identification of metabolites from an active fraction of water and ethyl-acetate extract of A. catechu, ethyl acetate fraction of S. robusta, ethyl acetate fraction of M. melabathrium, and hexane fraction of F. religiosa was carried out at Sophisticated Analytical Instrument Facility (SAIF), CSIR-Central Drug Research Institute, Lucknow. Samples were analyzed on an Agilent 6520, Accurate-Mass Q-TOF Mass Spectrometer equipped with a G1311A quaternary pump, G1329A autosampler, and G1315D diode array detector (DAD). The solvent system consists of acetonitrile (ACN) and 5mM acetate buffer and water at the flow rate of 0.5 ml/min. The initial condition started from 5% ACN for 0.1 min to 30% ACN for 6 min, 80% ACN for 20 min, and back to its initial conditions. During the whole process, column temperature was maintained at 30°C. After passing through the DAD flow cell, the column elute was directed to Q-TOF HRMS fitted with an electrospray interface (ESI). The MS analysis was carried out using an ESI-positive ionization mode with mass ranges from 100–3000 Da. Raw data obtained from the LC/HRMS system were converted to mzML format using the ProteoWizard tool MSConvertGUI [71]. MZmine 2 was used for peak detection, peak alignment, and identification (target compound annotation) using centroid data [7173].

2.10. Data Analysis

The results were processed by using Gen5 Microplate Data Collection and Analysis Software and then by MS Excel. The IC50 (inhibition of enzymatic hydrolysis of the substrate pNPG and CNPG3 by 50%) value was calculated using the Graphpad Prism software version 8. Values were expressed as a mean ± standard error of the mean of triplicate. The LC-HRMS metabolic was processed in an untargeted manner with MZmine 2 and used MestreNova 12.0 tool to annotate the molecules. The metabolites were searched using the Pubchem database, and Dictionary of Natural Products 2.

3. Results and Discussion

3.1. Total Phenolic and Flavonoid Contents

The TPC and TFC were expressed as the GAE/g, and QE/g of extract using a calibration curve of gallic acid and quercetin, respectively. The TPC of plant extracts follows the order A. catechu > S. robusta > M. malabathricum > F. religiosa. Likewise, the TFC of plant extracts follows the order S. robusta > M. malabathricum > F. religiosa>A. catechu, which are shown in Table 1S.

3.2. Free Radical Scavenging Activity

In this study, the antioxidant activities of crude extracts of plants are shown in Table 2S. DPPH radical scavenging results were reported as IC50 and compared with the IC50 value of quercetin (6.3 ± 1.0 µg/mL) as a standard. The radical scavenging ability of plant extracts follows the order F. religiosa (67.4 ± 0.6 µg/mL) > M. malabathricum (74.9 ± 5.6 µg/mL) > A. catechu (84.9 ± 1.9 µg/mL) > S. robusta (111.4 ± 1.1 µg/mL). The antioxidant ability is shown by providing hydrogen or electrons from the phytochemicals within extracts to free radicals.

3.3. α-Glucosidase Inhibitory Activity

The results of α-glucosidase inhibitory activity of the extracts are given in Table 2. Among the tested fraction, ethyl acetate and water fraction showed the most potent activity with an IC50 value ranging within 9–114.9 µg/mL against the α-glucosidase enzyme as compared to acarbose (IC50 = 344.23 ± 1.03 µg/mL). The ethyl acetate fraction of plants understudy on α-glucosidase inhibitory activity follows the order as M. malabathricum > S. robusta > F. religiosa > A. catechu while that of aqueous fraction follows A. catechu > M. malabathricum > S. robusta > F. religiosa.


PlantsCrude extractHexane fractionDCM fractionEthyl acetate fractionWater fraction
GAGAGAGAGA

A. catechu23.7 ± 0.7115 ± 4.0<50%<50%75.1 ± 3.6<50%57.6 ± 1.9<50%9.0 ± 0.673.2 ± 4.3
F. religiosa28.5 ± 0.729.2 ± 1.218.2 ± 0.270.2 ± 5.8<50%<50%24.7 ± 0.178.93 ± 1.1114.9 ± 2.7<50%
M. malabathricum82.6 ± 3.0221.2 ± 1.9<50%<50%<50%<50%9.1 ± 0.3213.5 ± 2.411.6 ± 0.6<50%
S. robusta34.8 ± 0.789.1 ± 0.8188.5 ± 2.4<50%200.8 ± 4.6<50%21.4 ± 0.569.3 ± 1.150.9 ± 1.5<50%

G: α-glucosidase and A: α-amylase.
3.4. α-Amylase Inhibitory Activity

In the α-amylase assays (Table 2), crude methanol extracts and their ethyl acetate fractions effectively inhibited the enzyme activity compared to other fractions. Crude extracts of F. religiosa followed by that of S. robusta and A. catechu showed antidiabetic activity with an IC50 of 29.24 ± 1.173, 89.127 ± 0.758, and 115 ± 4.004 µg/mL, respectively, compared to acarbose (IC50 = 6.1 ± 0.1 µg/mL). The hexane fraction of F. religiosa bark extract inhibited α-amylase with IC50 of 68.234 ± 5.812 µg/mL. Only the aqueous fraction of A. catechu was significant towards α-amylase.

3.5. Antimicrobial Activity

Antimicrobial activity of different fractions of plants was tested against ATCC strains such as Staphylococcus aureus ATCC 43300, Escherichia coli ATCC 2591, Klebsiella pneumoniae ATCC 700603, Salmonella typhi ATCC 14028, and Shigella sonnei ATCC 25931. The ZoI of each fraction of plants is shown in Table 3. The representative pictures showing ZoI of A. catechu extract against S. aureus ATCC 43300 and E. coli ATCC 2591 are shown in Figure 1S.


Acacia catechu (fraction)Shorea robusta (fraction)Melastoma malabathricum (fraction)Ficus religiosa (fraction)PC
HDEWHDEWHDEWHDEW

S. aureus10912149101010
E. coli716
K. pneumoniae96101378810819
S. typhi18
S. soni691110814158161571025

H: hexane; D: DCM; E: ethyl acetate; W: water; PC: positive control (neomycin).
3.6. Minimum Inhibitory and Bactericidal Concentration

Different fractions were examined for MIC and MBC against five ATCC strains such as S. aureus ATCC 43300, E. coli ATCC 25931, K. pneumonia ATCC 700603, S. typhi ATCC 14028, and S. sonnei ATCC 25931. The MIC of different fractions against ATCC reference strains was found between 0.3 mg/mL and 25 mg/mL shown in Table 4. M. malabathricum and S. robusta extract showed inhibition at lower concentrations, but it requires more concentration to kill the bacterial growth, as evidence by MIC and MBC values. MIC of water fraction of A. catechu and ethyl acetate fraction of F. religiosa against K. pneumonia ATCC 700603 is shown in Figure 2S. Likewise, MBC of ethyl acetate fraction of A. catechu and M. malabathricum against S. sonnei ATCC 25931 is shown in Figure 3S.


Acacia cathecuShorea robustaMelostoma malabathricumFicus religiosaPositive control
MICMBCMICMBCMICMBCMICMBCMICMBC

S. aureus3.1250.36.253.1253.112.50.0620.25
E. coli12.5500.0040.008
K. pneumoniae12.5256.25250.0040.008
S. typhi0.0040.03
S. sonnei6.2512.56.25251.56253.1212.50.0020.06

3.7. Molecular Annotation

The raw data of LC-HRMS were processed using MZmine and MestreNova 12.0 tool was used for further analysis. The total ion chromatogram (TIC) of the fractions subjected for LC-HRMS analysis is shown in Figure 4S. These results were verified with available public compound databases. Compounds were annotated from the fractions of all 4 plants. The annotated molecules from our spectra are catechin (Figure 5S), epicatechin (Figure 5S), gallocatechin (Figure 6S), epigallocatechin (Figure 6S), procyanidin (Figure 7S), emodin (Figure 8S), quercetin (Figure 9S), gossypin (Figure 10S), bergenin (Figure 11S), quercetin 3- O-β-D-apiofuranosyl(1 ⟶ 2)-[6-O-(3-hydroxy-3-methylglutaroyl)]-β-D-glucopyranoside (Figure 12S), quercetin 7-methyl ether 3-[3-hydroxy-3-methylglutaryl-(1->6)]-[apiosyl-(1->2)-galactoside] (Figure 13S), avicularin (quercetin 3-α -L-arabinofuranoside) (Figure 14S), kaempferol 3-O-α-L-arabinopyranoside (Figure 15S), quercetin 3-O-(6”-O-galloyl)-β-glucopyranoside (Figure 16S), kaempferol (Figure 17S), isoquercetin (Figure 18S), and dorsteniol (Figure 19S) which are shown in Table 5 (Figure 1).


Annotated compoundsCalculated MassObserved MassFormulaDouble bond equivalenceAbsolute error (ppm)Retention time (tR) minuteSource

Catechin or epicatechin290.07291.08C15H14O690.166.25A. catechu (W and E)
Gallocatechin or epigallocatechin306.07307.08C15H14O790.655.22A. catechu (W and E)
Procyanidin578.15579.15C30H26O12180.795.87A. catechu (W and E)
Emodin270.05271.06C15H10O5112.818.65A. catechu (E)
Quercetin302.04303.05C15H10O7113.658.04S. robusta/A. catechu/M. malabathricum (E)
Gossypin480.09481.09C21H20O13121.848.8S. robusta (E)
Bergenin328.08329.08C14H16O972.915.11S. robusta (E)
Quercetin 3- O-β-D-apiofuranosyl(1 ⟶ 2)-[6-O-(3-hydroxy-3-methylglutaroyl)]-β-D-glucopyranoside740.18741.18C32H36O20154.3111.52S. robusta (E)
Quercetin 7-methyl ether 3-[3-hydroxy-3-methylglutaryl-(1->6)]-[apiosyl-(1->2)-galactoside]754.19755.19C33H38O201512.76S. robusta (E)
Avicularin (quercetin 3-α -L-arabinofuranoside)435.09434.08C20H18O11123.97.83S. robusta (E)
Kaempferol 3-O-α-L-arabinopyranoside418.08419.08C20H18O10122.838.22S. robusta (E)
Quercetin 3-O-(6”-O-galloyl)-β-glucopyranoside616.1617.11C28H24O16170.657.16M. malabathricum (E)
Kaempferol286.04287.05C15H10O6110.198.69M. malabathricum (E)
Isoquercetin464.09465.1C21H20O12120.437.58M. malabathricum (E)
Dorsteniol262.08263.09C14H14O581.198.14F. religosa (H)

E: ethyl acetate; W: water; H: hexane.

4. Discussion

Plants synthesize a wide range of secondary metabolites which showed broad-spectrum enzyme inhibitory potential. Nepal is a Himalayan nation with lopsidedly rich flora and fauna located at a transition zone between the flora of the Western Himalaya and the Eastern Himalaya [74]. The assorted variety of species in Nepalese flora offers incredible open doors for the hunt of medicinal substances. Nepal has been underexplored in terms of medicinal plants. Due to poor infrastructures and funding in research, most of the analytics have not been explored out of its biodiverse flora and fauna. Though there are some works in the past, most of them are restricted only up to the crude activity. No research group has gone so far as to annotate compounds from Nepalese plants. Khadayat et al. studied the α-amylase inhibitory activity of Nepalese medicinal plants up to crude extract. Aryal et al. and Phuyal et.al. studied only TPC, TFC, and antioxidant potential of plants available in Nepal [68, 75, 76]; Sai et al. and Subba et al. studied phytochemical screening, antioxidant and α-amylase inhibitory activities of medicinal plants from Nepal [77, 78]. Since natural products have contributed 48.64% as a source of new drugs for diabetes [79], we aim to annotate secondary metabolites from Nepalese plants covered by multiple pharmacological applications based on previous experiments.

Compounds like quercetin, ferulic acid, anthocyanins, catechin, and resveratrol, which are plant-based phenolics and flavonoids, are responsible for regulating glycemia through insulin secretion, increased glucose uptake, lipid peroxidation inhibition, and inhibition of enzymes like α-glucosidase, and α-amylase [80, 81]. Due to the vast health benefits such as antioxidant, antimicrobial, antiulcer, antidiabetic, hepatoprotective, and anticarcinogenic activities of phenolic and flavonoid compounds, thus they are considered as a major class of phytochemicals [82, 83].

Previously, evidence of antidiabetic activity of M. malabathricum leaves extract has been shown by in vivo experiments on diabetes-induced rats [47, 84] to support our results. A. catechu (L.f.) Willd. leaf extracts showed an IC50 of 0.4977 mg/mL against α-glucosidase [85]. Similarly, kaempferol, quercetin, naringenin, and baicalein were the flavonoids isolated from F. racemosa stem bark showing a significant decrease in blood glucose levels in diabetes-induced albino Wistar rats [86]. Additionally, gossypetin, herbacetin, kaempferol, leucoperalgonidin, leucodelphinidin, and sorbifolin from Ficus species were shown as potential digestive enzymes inhibitors through in silico analysis [87].

Phenolic and flavonoid compounds play a major role in free radical scavenging activity via chain termination of free radicals that depend on hydroxyl groups’ number and position by donating hydrogen atoms [88]. The structural features like many hydroxyl groups and their configuration, the ketonic functional group at C-4, and a double bond at C2–C3 on flavonoids enhanced the antioxidant ability [89, 90]. Due to these structural features, extracts with higher phenolic compounds are already proved to have a higher antidiabetic ability via the formation of hydrogen bonds and hydrophobic interactions with enzymes and reduce their activity [91, 92]. There are high correlations between antioxidant capacity and total phenols and total flavonoids, so the presence of a high concentration of phenolic compounds also has high antioxidant activity [75]. There is no correlation between high TPC and TFC value with high antioxidant activity in our study. Bioactive compounds present in plant extracts showed antidiabetic activity by inhibiting glucose absorption in the intestinal tract (inhibiting the different steps of carbohydrates digestion) or antioxidant ability [93].

Phytochemicals such as vitamins (A, C, E, and K), carotenoids, terpenoids, flavonoids, polyphenols, alkaloids, tannins, saponins, pigments, enzymes, and minerals have antimicrobial and antioxidant activity [13, 14]. The antimicrobial activity of extracts from different parts of A. catechu [22, 9497], F. religiosa [98], M. malabathricum [55, 99], and S. robusta [100] has been shown previously. However, the variation in activity is mainly due to diversities in phytochemicals. A. catechu extracts inhibit the growth of Bacillus subtilis, S. aureus, S. typhimurium E. coli, and Pseudomonas aeruginosa with MIC of 1,000 µg/mL against S. aureus and B. subtilis while that for S. typhimurium, E. coli, and P. aeruginosa was 700, 1,500, and ≤2,000 µg/mL, respectively [22]. M. malabathricum has been shown with activity against S. aureus, B. subtilis, B. cereus, E. coli, P. aeruginosa, S. typhi, and K. pneumonia [55]. Ismail showed extracts from Melastoma species exhibited MIC activity ranges from 12.5 to 100 mg/mL against E. coli, P. Aeruginosa, B. cereus, and S. aureus [101]. Antimicrobial activity of S. robusta against P. aeruginosa, S. aureus, E. coli, E. faecalis, C. albicans, and A. niger showed ZoI of 7–25 mm [100].

Catechin, epicatechin, and taxifolin from A. catechu [26, 96]; ursolic acid, 2α-hydroxyursolic acid, asiatic acid, β-sitosterol 3-O-β-D-glucopyranoside, quercetin, ellagic acid, and kaempferol from M. malabathricum [55]; and amarogentin, amaroswerin, gentianine, mangiferin, oleanolic acid, swechirin, swertiamarin, sweroside, swertanoone, ursolic acid, etc. from S. chirayita [102, 103] were identified with antibacterial ability.

The mechanism behind the antimicrobial activity of phenolic compounds and flavonoids is the inhibition of nucleic acid synthesis, cytoplasmic membrane function, energy metabolism, attachment and biofilm formation, and porin on the cell membrane, and membrane permeability alteration leading to cell destruction as well as attenuation of pathogenicity [104]. In our study, most of the extracts showed higher antibacterial activity against gram-positive bacteria as compared to gram-negative bacteria; it might be due to differences in the cell wall structure as the peptidoglycan layer in gram-positive bacteria is an ineffective permeability barrier as compared to gram-negative bacteria containing outer membrane and a unique periplasmic space rich in lipopolysaccharide molecules, which act as a barrier for the penetration of numerous antimicrobial compounds [105].

The most time-consuming steps are metabolite identification. Because of the time-consuming and the availability of plant materials, we performed LC/HRMS for metabolite profiling based on in vitro assay rather than performing high-performance liquid chromatography (HPLC), LC-HRMS/MS, and nuclear magnetic resonance (NMR). Likewise, after performing LC-HRMS we proceeded with our raw data with MZmine and overlayed our ion chromatogram. A. catechu may contain catechin or epicatechin: base peak m/z 291.086 (elemental composition C15H14O6; tR 6.25); fragments peak at 139 and [M + Na]+ peak at m/z 313.2 comparing our result with Hye et al., Ibrahim et al., Shen et al., and Wang et al., [106109]. The fragmentation pattern of catechin/epicatechin is shown in Figure 20S. It is predicted to be gallocatechin/epigallocatechin and procyanidin: in our spectra, we observed [M + H]+ peak m/z 307.08 (C15H14O7; tR 5.22); fragment peak at m/z 289 and 139 for gallocatechin/epigallocatechin. The fragmentation pattern of gallocatechin/epigallocatechin is shown in Figure 21S. Likewise, the molecular ion peak at m/z 579.15 (C30H26O12; tR 5.79) with catechin-like RDA fragment [M + H − 152]+ at m/z 427.13 is speculated as procyanidin similar to the study by Shen et al. [108]. Additionally, the quasimolecular ion peak at m/z 271.06 (C15H10O5; tR 18.65) with fragment peak at m/z 253, 243, 229, 225, and 197 is annotated as emodin consistent with the study by Zhan et al. The fragmentation pattern of emodin is shown in Figure 22S.

The absence of myricetin and the presence of proanthocyanidin in the leaves of S. robusta were very significant [111, 112]. Base peak with m/z 303.051 (C15H10O7; tR 8.04) was expected to be quercetin. The fragmentation pattern of the quercetin is shown in Figure 23S. Similarly, base peak with m/z 481.09 (C21H20O20; tR 6.82) and the fragment ion at m/z = 319.05 and 287.15 is interpreted as gossypin comparing our spectra with Giorio et al. and Petsalo et al. [113, 114]. The base peak at m/z 329.08 (molecular formula C14H16O9; tR 5.11) and quasi molecular ion peak [M + Na]+ at m/z 351.06 are expected to be bergenin isolated from S. robusta with reference from the data collected from our spectra and Mukherjee et al. [60]. The other flavonoid is expected to be quercetin 3- O-β-D-apiofuranosyl(1 ⟶ 2)-[6-O-(3-hydroxy-3-methylglutaroyl)]-β-D-glucopyranoside: base peak m/z 741.18 (C32H36O20; tR 11.52), [M + Na]+ m/z = 763.16 and the fragment ion at m/z = 609.16 [M + H − 132 (pentose)]+ with reference from the data collected from our spectra and Fu et al., 2010 [115]. Adding 14 Da mass on quercetin 3-O-β-D-xylopyranosyl(1 ⟶ 2)-[6-O-(3-hydroxy-3-methylglutaroyl)]-β-D-glucopyranoside yields mass equals 755 which could be quercetin 7-methyl ether 3-[3-hydroxy-3-methylglutaryl-(1->6)]-[apiosyl-(1->2)-galactoside] [116]. Likewise, the base peak with m/z 435.09 (C20H18O11; tR 7.83) and fragments peak at m/z 303.05, 287.05, 183.14, and 153.02 are predicted to be avicularin (quercetin 3-α -L-arabinofuranoside) as spectral figures match with the literature of Santos et al. [117]. Moreover, in our spectra, the base peak with m/z 419.09 (C20H18O10; tR 8.22) and fragments peak at m/z 287.09 ([(M + H) − 132]) are annotated as kaempferol 3-O-α-L-arabinopyranoside taking reference of Vuković et al. [118].

M. melabathrium may contain isoquercetin since in our spectra at base peak m/z 465.10 (tR 7.58) and fragments ions at m/z 303.04 (quercetin) and 289.06 (kaempferol) exactly match with the spectra data of Liu et al. [119]. Base peak at m/z 617.11 (tR 7.16) and fragments ions at m/z 303.05 corresponding to [aglycone + H]+ and at m/z 315.07 corresponding to [sugar + gallic acid + H]+ are assumed to be quercetin 3-O-(6”-O-galloyl)-β-glucopyranoside taking reference of Şöhretoğlu et al. [120]. The other metabolite was reported as kaempferol with base peak m/z 287.05 (C15H10O6; tR 8.69) and fragments ion at m/z 259.12, 165.05, 153.0, 127.03, and 121.09 respectively. The spectra are similar to March et al. [121]. The fragmentation pattern of kaempferol is shown in Figure 24S. Similarly, from MZmine total ion chromatogram (TIC) we can say that the M. melabathrium and S. robusta may contain quercetin at base peak m/z 303 as we can observe the peak of quercetin coinciding in both plants.

In hexane fraction of F. religiosa, we did defatting by removing the first hexane fraction. But the chromatogram was also seen in our mass spectrometry with fairly fewer amounts. Then, we annotated dorsteniol secondary metabolites in F. religiosa. Literature search shows that Ficus species contain dorsteniol. Our spectra data shows base peak at m/z 263.09 (C14H14O5; tR 8.14) and [M + Na]+ peak at m/z 285.07 as in Alqasoumi et al. [122]. So, the predicted compound is dorsteniol.

In our study, we have annotated 17 secondary metabolites from different plant extract. To support our annotation, more spectroscopic data are required. Crude extracts showed potent activity due to the synergistic effect of compounds. Besides that, ethyl acetate and water fraction showed potent activity; this might be due to phenolic and flavonoid compounds present in those solvents. In some extracts, hexane and DCM showed good inhibition due to terpenes, steroids, and diterpenes present in extracts.

5. Conclusions

Due to the rising prevalence of diabetes and antimicrobial resistance, the quest for novel drugs from natural sources persists. The scientific study of different traditional medicinal plants used by diverse groups of people is necessary. Traditional medicinal plants that local peoples have used were screened for antioxidant, antimicrobial, and antidiabetic assay. Among 4 selected medicinal plants from Nepal, most extracts and their fractions can show antioxidant, antimicrobial, and antidiabetic activity, supporting these plants’ traditional use. Further works can be carried out on isolation, identification, in silico, and kinetics of potential inhibitors from an active fraction of plant extracts used as a drug candidate for diabetes.

Abbreviations

DPPH:2,2-Diphenyl-1-picrylhydrazyl
DM:Diabetes mellitus
CNPG3:2-Chloro-4-nitrophenyl-α-D-maltotrioside
IDF:International Diabetes Federation
LC-HRMS:Liquid chromatography-high resolution mass spectrometry;
MHB:Mueller Hinton Broth
MIC:Minimum inhibitory concentration
MBC:Minimum bactericidal concentration
PNPG:4-Nitrophenyl-α-D-glucopyranoside
tR:Retention time
ZoI:Zone of inhibition
MDR:Multidrug resistance
SEA:Southeast Asia
CLSI:Clinical and laboratory standards institute
TIC:Total ion chromatogram.

Data Availability

The data used to support the findings of this study are available from the corresponding author upon request.

Disclosure

This paper has been extracted from an MSc thesis by Babita Aryal and others carried out in Tribhuvan University, Kirtipur, Kathmandu, Nepal.

Conflicts of Interest

The authors declare no conflicts of interest.

Authors’ Contributions

N.P. designed research; B.A., P.N., K.K., B.A., D.KC., and B.K.S. performed research; B.A., K.K., B.A., N.A., and N.P. analyzed data; and B.A., K.K., B.R.B., and B.A. wrote the paper.

Acknowledgments

This project was supported by the Higher Education Reform Project (HERP), Tribhuvan University, to Niranjan Parajuli. Grateful acknowledgment is made to the Central Department of Botany, Tribhuvan University, Nepal, for plant identification. The authors are also thankful to the Sophisticated Analytical Instrument Facility (SAIF), CSIR-Central Drug Research Institute, Lucknow, India, for mass analysis.

Supplementary Materials

Table 1S: Total phenolic and flavonoids content of different plants. Table 2S: Antioxidant ability of plant extracts. Figure 1S: Antimicrobial activity of A. catechu extracts against S. aureus ATCC 43300 and E. coli ATCC 2591. Figure 2S: MIC of ethyl acetate of A. catechu and F. religiosa against S. sonnei ATCC 25931. Figure 3S: MBC of ethyl acetate fraction of A. catechu and M. malabathricum against S. sonnei ATCC 25931. Figure 4S: Total ion chromatogram (TIC) of (a) dark blue line: A. catechu ethyl acetate fraction, (b) red line: S. robusta ethyl acetate fraction, (c) green line: A. catechu water fraction, (d) pink line: M. malabathricum ethyl acetate fraction, and (e) sky blue line: F. religiosa hexane fraction. Figure 5S: Mass spectrum of catechin or epicatechin from A. catechu. Figure 6S: Mass spectrum of gallocatechin or epigallocatechin from A. catechu. Figure 7: mass spectrum of procyanidin from A. catechu. Figure 8S: Mass spectrum of emodin from A. catechu. Figure 9S: mass spectrum of quercetin from S. robusta. Figure 10S: Mass spectrum of gossypin from S. robusta. Figure 11S: Mass spectrum of bergenin acid from S. robusta. Figure 12S: Mass spectrum of quercetin 3-O-β-D-apiofuranosyl (1 ⟶ 2)-[6-O-(3-hydroxy-3-methylglutaroyl)]-β-D-glucopyranoside from S. robusta. Figure 13S: Mass spectrum of quercetin 7-methyl ether 3-[3-hydroxy-3-methylglutaryl-(1->6)]-[apiosyl-(1->2)-galactoside] from S. robusta. Figure 14S:Mass spectrum of avicularin (quercetin 3-α -L-arabinofuranoside) from S. robusta. Figure 15S: Mass spectrum of kaempferol 3-O-α-L-arabinopyranoside from M. malabathricum. Figure 16S: Mass spectrum of quercetin 3-O-(6”-O-galloyl)-β-glucopyranoside from M. malabathricum. Figure 17S: Mass spectrum of kaempferol from M. malabathricum. Figure 18S: Mass spectrum of isoquercetin from M. malabathricum. Figure 19S: Mass spectrum of dorsteniol from F. religiosa. Figure 20S: Fragmentation pattern of catechin/epicatechin. Figure 21S: Fragmentation pattern of gallocatechin/epigallocatechin. Figure 22S: Fragmentation pattern of emodin. Figure 23S: Fragmentation pattern of quercetin derivatives. Figure 24S: Fragmentation pattern of kaempferol. (Supplementary Materials)

References

  1. N. Balasundram, K. Sundram, and S. Samman, “Phenolic compounds in plants and agri-industrial by-products: antioxidant activity, occurrence, and potential uses,” Food Chemistry, vol. 99, no. 1, pp. 191–203, 2006. View at: Publisher Site | Google Scholar
  2. A. Zhang, H. Sun, and X. Wang, “Recent advances in natural products from plants for treatment of liver diseases,” European Journal of Medicinal Chemistry, vol. 63, pp. 570–577, 2013. View at: Publisher Site | Google Scholar
  3. P. Sheng-Ji, “Ethnobotanical approaches of traditional medicine studies: some experiences from Asia,” Pharmaceutical Biology, vol. 39, no. 1, pp. 74–79, 2001. View at: Publisher Site | Google Scholar
  4. A. Sharma, R. Verma, and P. Ramteke, “Antibacterial activity of some medicinal plants used by tribals against uti causing pathogens,” World Applied Sciences Journal, vol. 7, 2008. View at: Google Scholar
  5. J. Klepacka, E. Gujska, and J. Michalak, “Phenolic compounds as cultivar- and variety-distinguishing factors in some plant products,” Plant Foods for Human Nutrition, vol. 66, no. 1, pp. 64–69, 2011. View at: Publisher Site | Google Scholar
  6. D. Kalauni and A. Joshi, “Status of medicinal and aromatic plant (maps) and socio-economic influence in Nepalese livelihood-a review research,” Acta Scientific Agriculture, vol. 2, pp. 123–130, 2018. View at: Google Scholar
  7. J. L. S. Taylor, T. Rabe, L. J. McGaw, A. K. Jäger, and J. Van Staden, “Towards the scientific validation of traditional medicinal plants,” Plant Growth Regulation, vol. 34, no. 1, pp. 23–37, 2001. View at: Publisher Site | Google Scholar
  8. IDF, Diabetes Atlas, International Diabetes Federation, Brussels, Belgium, 9th edition, 2019, https://www.diabetesatlas.org/upload/resources/2019/IDF_Atlas_9th_Edition_2019.html.
  9. E. L. Y. Yam, L. Y. Hsu, E. P.-H. Yap, T. W. Yeo, V. Lee, and J. Schlundt, “Antimicrobial resistance in the Asia Pacific region: a meeting report,” Antimicrobial Resistance & Infection Control, vol. 8, p. 202, 2019. View at: Publisher Site | Google Scholar
  10. L. Othman, A. Sleiman, and R. M. Abdel-Massih, “Antimicrobial activity of polyphenols and alkaloids in middle eastern plants,” Frontiers in Microbiology, vol. 10, 2019. View at: Publisher Site | Google Scholar
  11. E. Middleton, “Biological properties of plant flavonoids: an overview,” International Journal of Pharmacognosy, vol. 34, pp. 344–348, 1996. View at: Google Scholar
  12. M. D. E. Biological, “Properties of plant flavonoids: an overview,” Pharmaceutical Biology, vol. 34, pp. 344–348, 2008. View at: Google Scholar
  13. G. G. F. Nascimento, J. Locatelli, P. C. Freitas, and G. L. Silva, “Antibacterial activity of plant extracts and phytochemicals on antibiotic-resistant bacteria,” Brazilian Journal of Microbiology, vol. 31, pp. 247–256, 2000. View at: Publisher Site | Google Scholar
  14. A. A. Shad, S. Ahmad, R. Ullah, N. M. AbdEl-Salam, H. Fouad, and N. U. Rehman, “Phytochemical and biological activities of four wild medicinal plants,” Scientific World Journal, vol. 2014, 2014. View at: Publisher Site | Google Scholar
  15. G. Siuzdak, An Introduction to Mass Spectrometry Ionization: An Excerpt from the Expanding Role of Mass Spectrometry in Biotechnology, MCC Press, San Diego, CA, USA, 2nd edition, 2005.
  16. M. A. Salem, L. Perez de Souza, A. Serag et al., “Metabolimics in the context of plant natural products research: from sample preparation to metabolite analysis,” Metabolites, vol. 10, no. 1, p. 37, 2020. View at: Publisher Site | Google Scholar
  17. S. Singh and S. K. Verma, “Study of the distribution profile of piperidine alkaloids in various parts of Prosopis juliflora by the application of Direct Analysis in Real Time Mass Spectrometry (DART-MS),” Natural Products and Bioprospecting, vol. 2, no. 5, pp. 206–209, 2012. View at: Publisher Site | Google Scholar
  18. M. Petrović, M. D. Hernando, M. S. Díaz-Cruz, and D. Barceló, “Liquid chromatography–tandem mass spectrometry for the analysis of pharmaceutical residues in environmental samples: a review,” Journal of Chromatography A, vol. 1067, pp. 1–14, 2005. View at: Google Scholar
  19. S. Banerjee and S. Mazumdar, “Electrospray ionization mass spectrometry: a technique to access the information beyond the molecular weight of the analyte,” International Journal of Analytical Chemistry, vol. 2012, Article ID e282574, pp. 1–40, 2012. View at: Publisher Site | Google Scholar
  20. R. M. Kunwar, K. P. Shrestha, and R. W. Bussmann, “Traditional herbal medicine in Far-west Nepal: a pharmacological appraisal,” Journal of Ethnobiology and Ethnomedicine, vol. 6, no. 1, p. 35, 2010. View at: Publisher Site | Google Scholar
  21. T. Lakshmi, D. Ezhilarasan, R. Vijayaragavan, S. K. Bhullar, and R. Rajendran, “Acacia catechu ethanolic bark extract induces apoptosis in human oral squamous carcinoma cells,” Journal of Advanced Pharmaceutical Technology & Research, vol. 8, pp. 143–149, 2017. View at: Google Scholar
  22. B. S. Negi and B. P. Dave, “In vitro antimicrobial activity of Acacia catechu and its phytochemical analysis,” Indian Journal of Microbiology, vol. 50, no. 4, pp. 369–374, 2010. View at: Publisher Site | Google Scholar
  23. X. Li, H. Wang, C. Liu, and R. Chen, “Chemical constituents of Acacia catechu,” Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica, vol. 35, pp. 1425–1427, 2010. View at: Google Scholar
  24. X.-C. Li, C. Liu, L.-X. Yang, and R.-Y. Chen, “Phenolic compounds from the aqueous extract of Acacia catechu,” Journal of Asian Natural Products Research, vol. 13, no. 9, pp. 826–830, 2011. View at: Publisher Site | Google Scholar
  25. V. G. Devi, A. John, R. S. Devi, and V. A. Prabhakaran, “Pharmacognostical studies on Acacia catechu willd and identification of antioxidant principles,” International Journal of Pharmacy and Pharmaceutical Sciences, vol. 3, p. 4, 2011. View at: Google Scholar
  26. S. T. Ahamad, T. Lakshmi, S. Rajeshkumar, A. Roy, D. Gurunadhan, and R. Geetha, “Antibacterial activity of taxifolin isolated from Acacia catechu leaf extract-an invitro study,” Indian Journal of Public Health Research & Development, vol. 10, no. 11, p. 3540, 2019. View at: Publisher Site | Google Scholar
  27. S. S. Hong, Y.-H. Choi, H.-J. Suh et al., “Flavonoid constituents of Acacia catechu,” Journal of Applied Biological Chemistry, vol. 58, no. 2, pp. 189–194, 2015. View at: Publisher Site | Google Scholar
  28. S. E. Drewes and D. G. R. Roux, Condensed Tannins Leather Industrie8 Research Institute, Rhodes University, Grahamstowr, South Africa, 1962.
  29. T. Lakshmi, R. Ramasamy, and R. Thirumalaikumaran, “Preliminary phytochemical analysis and in vitro antioxidant, FTIR spectroscopy, anti-diabetic activity of Acacia catechu ethanolic seed extract,” Pharmacognosy Journal, vol. 6, pp. 356–362, 2015. View at: Google Scholar
  30. D. Sharma, C. Dangi, and M. Kaur, “A review on pharmacological activities and therapeutic potentials of ficus religiosa (pipal). life science,” Indian Journal of Applied Research, vol. 623, pp. 624–626, 2016. View at: Google Scholar
  31. S. Singh and S. Jaiswal, “Therapeutic properties of Ficus religiosa,” International Journal of Engineering Research and General Science, vol. 2, pp. 149–158, 2014. View at: Google Scholar
  32. R. Jangde, “Plant profile Ficus religiosa: a review,” Research Journal of Science and Technology, vol. 7, no. 4, p. 193, 2015. View at: Publisher Site | Google Scholar
  33. N. Akhtar, S. Iqbal, M. F. Shahzad, M. Latif, and F. Iqbal, “Oral supplementation of Ficus religiosa leaf extract adversely affects the selected behavioral aspects of male albino mice,” Biologia, vol. 75, no. 12, pp. 2295–2300, 2020. View at: Publisher Site | Google Scholar
  34. O. Mousa, P. Vuorela, J. Kiviranta, S. A. Wahab, R. Hiltunen, and H. Vuorela, “Bioactivity of certain Egyptian Ficus species,” Journal of Ethnopharmacology, vol. 41, no. 1-2, pp. 71–76, 1994. View at: Publisher Site | Google Scholar
  35. R. M. Charde, H. J. Dhongade, M. S. Charde, and E. Z. Building, “Evaluation of antioxidant, wound healing and anti-inflammatory activity of ethanolic extract of leaves of Ficus religiosa,” International Journal of Pharmaceutical Sciences and Research, vol. 1, pp. 32–40, 2010. View at: Google Scholar
  36. R. Pandit, A. Phadke, and A. Jagtap, “Antidiabetic effect of Ficus religiosa extract in streptozotocin-induced diabetic rats,” Journal of Ethnopharmacology, vol. 128, no. 2, pp. 462–466, 2010. View at: Publisher Site | Google Scholar
  37. H. Kaur, D. Singh, B. Singh, and R. K. Goel, “Anti-amnesic effect of Ficus religiosain scopolamine-induced anterograde and retrograde amnesia,” Pharmaceutical Biology, vol. 48, no. 2, pp. 234–240, 2010. View at: Publisher Site | Google Scholar
  38. M. A. Fernández, B. de las Heras, M. D. García, M. T. Sáenz, and A. Villar, “New insights into the mechanism of action of the anti-inflammatory triterpene lupeol,” The Journal of Pharmacy and Pharmacology, vol. 53, no. 11, pp. 1533–1539, 2001. View at: Publisher Site | Google Scholar
  39. M. I. Rashid, M. I. Fareed, H. Rashid et al., “Flavonoids and their biological secrets,” in Plant and Human Health, Phytochemistry and Molecular Aspects, M. Ozturk and K. R. Hakeem, Eds., Springer International Publishing, Cham, Switzerland, 2019. View at: Publisher Site | Google Scholar
  40. M. F. G. Rocha, J. A. Sales, M. G. da Rocha et al., “Antifungal effects of the flavonoids kaempferol and quercetin: a possible alternative for the control of fungal biofilms,” Biofouling, vol. 35, no. 3, pp. 320–328, 2019. View at: Publisher Site | Google Scholar
  41. A. Ali, M. Jameel, and M. Ali, “New naphthyl esters from the bark of Ficus religiosa Linn,” The Natural Products Journal, vol. 4, 2014. View at: Publisher Site | Google Scholar
  42. S. M. Manorenjitha, “Chemical profile of Ficus religiosa (Linn.) stem,” International Journal of Life Science and Medical Research, vol. 4, pp. 32–37, 2014. View at: Google Scholar
  43. A. Poudel, P. Satyal, and W. N. Setzer, “Composition and bioactivities of the leaf essential oil of Ficus religiosa Linn,” American Journal of Essential Oils and Natural Products, vol. 2, pp. 16-17, 2015. View at: Google Scholar
  44. L. Grison-Pigé, M. Hossaert-McKey, J. M. Greeff, and J.-M. Bessière, “Fig volatile compounds-a first comparative study,” Phytochemistry, vol. 61, no. 1, pp. 61–71, 2002. View at: Publisher Site | Google Scholar
  45. I. K. Makhija, I. P. Sharma, and D. Khamar, “Phytochemistry and pharmacological properties of Ficus religiosa: an overview,” Annals of Biological Research, vol. 1, pp. 171–180, 2010. View at: Google Scholar
  46. S. Hossan, B. Agarwala, S. Sarwar, M. Karim, R. Jahan, and M. Rahmatullah, “Traditional use of medicinal plants in Bangladesh to treat urinary tract infections and sexually transmitted diseases,” Ethnobotany Research and Applications, vol. 8, pp. 061–74, 2010. View at: Publisher Site | Google Scholar
  47. V. Kumar, D. Ahmed, P. S. Gupta, F. Anwar, and M. Mujeeb, “Anti-diabetic, anti-oxidant and anti-hyperlipidemic activities of Melastoma malabathricum Linn. leaves in streptozotocin induced diabetic rats,” BMC Complementary and Alternative Medicine, vol. 13, pp. 1–19, 2013. View at: Publisher Site | Google Scholar
  48. S. M. Joffry, N. J. Yob, M. S. Rofiee, M. M. R. M. M. Affandi, Z. Suhaili, and F. Othman, “Melastoma malabathricum (L.) smith ethnomedicinal uses, chemical constituents, and pharmacological properties: a review,” Evidence-based Complementary and Alternative Medicine, vol. 2012, pp. 6–20, 2012. View at: Publisher Site | Google Scholar
  49. J. Anbu, P. Jisha, R. Varatharajan, and M. Muthappan, “Antibacterial and wound healing activities of Melastoma malabathricum linn,” African Journal of Infectious Diseases, vol. 2, pp. 68–73, 2010. View at: Publisher Site | Google Scholar
  50. N. Uawonggul, A. Chaveerach, S. Thammasirirak, T. Arkaravichien, C. Chuachan, and S. Daduang, “Screening of plants acting against Heterometrus laoticus scorpion venom activity on fibroblast cell lysis,” Journal of Ethnopharmacology, vol. 103, no. 2, pp. 201–207, 2006. View at: Publisher Site | Google Scholar
  51. H. A. Hamid, M. M. Yusoff, M. Liu, and M. R. Karim, “α-Glucosidase and α-amylase inhibitory constituents of Tinospora crispa: isolation and chemical profile confirmation by ultra-high performance liquid chromatography-quadrupole time-of-flight/mass spectrometry,” Journal of Functional Foods, vol. 16, pp. 74–80, 2015. View at: Publisher Site | Google Scholar
  52. M. P. Mazura, D. Susanti, and M. A. Rasadah, “Anti-inflammatory action of components from Melastoma malabathricum,” Pharmaceutical Biology, vol. 45, no. 5, pp. 372–375, 2007. View at: Publisher Site | Google Scholar
  53. S. S. Mamat, M. Fauzi, F. Kamarolzaman, F. Yahya, N. D. Mahmood, and M. S. Shahril, “Methanol extract of Melastoma malabathricum leaves exerted antioxidant and liver protective activity in rats,” BMC Complementary and Alternative Medicine, vol. 13, p. 12, 2013. View at: Publisher Site | Google Scholar
  54. C. B. Lynn, “Establishment of cell suspension,” Production, vol. 117, 2008. View at: Google Scholar
  55. K.-C. Wong, D. M. Hag Ali, and P.-L. Boey, “Chemical constituents and antibacterial activity of Melastoma malabathricum L,” Natural Product Research, vol. 26, no. 7, pp. 609–618, 2012. View at: Publisher Site | Google Scholar
  56. M. S. Aslam, M. S. Ahmad, and M. A. Ahmad, “An up-to-date review on phytochemical constituents and pharmacological activities of Melastoma malabathricum,” International Journal of Pharmaceutical Sciences and Research, vol. 8, pp. 76–91, 2017. View at: Google Scholar
  57. D. Kumar, T. Wani, D. Kumar et al., “Analgesic activity of the ethanolic extract of Shorea robusta resin in experimental animals,” Indian Journal of Pharmacology, vol. 44, no. 4, p. 493, 2012. View at: Publisher Site | Google Scholar
  58. J. Liu, “Pharmacology of oleanolic acid and ursolic acid,” Journal of Ethnopharmacology, vol. 49, no. 2, pp. 57–68, 1995. View at: Publisher Site | Google Scholar
  59. B. Poornima, “Comparative phytochemical analysis of Shorea robusta Gaertn (oleoresin) WSR to its seasonal collection,” Ancient Science of Life, vol. 29, no. 1, pp. 26–28, 2009. View at: Google Scholar
  60. H. Mukherjee, D. Ojha, Y. P. Bharitkar et al., “Evaluation of the wound healing activity of Shorea robusta, an Indian ethnomedicine, and its isolated constituent(s) in topical formulation,” Journal of Ethnopharmacology, vol. 149, no. 1, pp. 335–343, 2013. View at: Publisher Site | Google Scholar
  61. N. Bainsal, P. Goyal, and J. Singh, “A multi-therapeutic potential indigenous drug,” Plant Archives, vol. 20, pp. 3313–3322, 2020. View at: Google Scholar
  62. E. A. Ainsworth and K. M. Gillespie, “Estimation of total phenolic content and other oxidation substrates in plant tissues using Folin-Ciocalteu reagent,” Nature Protocols, vol. 2, no. 4, pp. 875–877, 2007. View at: Publisher Site | Google Scholar
  63. X. Lu, J. Wang, H. M. Al-Qadiri et al., “Determination of total phenolic content and antioxidant capacity of onion (Allium cepa) and shallot (Allium oschaninii) using infrared spectroscopy,” Food Chemistry, vol. 129, no. 2, pp. 637–644, 2011. View at: Publisher Site | Google Scholar
  64. I. A. Ahmed, M. A. Mikail, M. bin Ibrahim et al., “Antioxidant activity and phenolic profile of various morphological parts of underutilised Baccaurea angulata fruit,” Food Chemistry, vol. 172, pp. 778–787, 2015. View at: Publisher Site | Google Scholar
  65. C.-C. Chang, M.-H. Yang, H.-M. Wen, and J.-C. Chern, “Estimation of total flavonoid content in propolis by two complementary colorimetric methods,” Journal of Food and Drug Analysis, vol. 10, 2002. View at: Publisher Site | Google Scholar
  66. W. Brand-Williams, M. E. Cuvelier, and C. Berset, “Use of a free radical method to evaluate antioxidant activity,” LWT - Food Science and Technology, vol. 28, no. 1, pp. 25–30, 1995. View at: Publisher Site | Google Scholar
  67. H. Fouotsa, A. M. Lannang, C. D. Mbazoa et al., “Xanthones inhibitors of α-glucosidase and glycation from Garcinia nobilis,” Phytochemistry Letters, vol. 5, no. 2, pp. 236–239, 2012. View at: Publisher Site | Google Scholar
  68. K. Khadayat, B. P. Marasini, H. Gautam, S. Ghaju, and N. Parajuli, “Evaluation of the alpha-amylase inhibitory activity of Nepalese medicinal plants used in the treatment of diabetes mellitus,” Clinical Phytoscience, vol. 6, no. 1, p. 34, 2020. View at: Publisher Site | Google Scholar
  69. M. Balouiri, M. Sadiki, and S. K. Ibnsouda, “Methods for in vitro evaluating antimicrobial activity: a review,” Journal of Pharmaceutical Analysis, vol. 6, no. 2, pp. 71–79, 2016. View at: Publisher Site | Google Scholar
  70. CLSI, Performance Standards for Antimicrobial Susceptibility Testing: 25th Informational Supplement (M100-S23), Clinical and Laboratory Standards Institute, Wayne, PA, USA, 2015.
  71. J. D. Holman, D. L. Tabb, and P. Mallick, “Employing ProteoWizard to convert raw mass spectrometry data,” Current Protocols in Bioinformatics, vol. 46, pp. 13–24, 2014. View at: Publisher Site | Google Scholar
  72. T. Pluskal, S. Castillo, A. Villar-Briones, and M. Orešič, “MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data,” BMC Bioinformatics, vol. 11, pp. 1–11, 2010. View at: Publisher Site | Google Scholar
  73. M. Katajamaa and M. Orešič, “Processing methods for differential analysis of LC/MS profile data,” BMC Bioinformatics, vol. 6, pp. 1–12, 2005. View at: Publisher Site | Google Scholar
  74. K. B. Shrestha, “Treeline and vegetation dynamics in response to environmental changes in Nepal, the central Himalaya,” University of Bergen, Bergen, Norway, 2013, Thesis. View at: Google Scholar
  75. S. Aryal, M. K. Baniya, K. Danekhu, P. Kunwar, R. Gurung, and N. Koirala, “Total phenolic content, flavonoid content and antioxidant potential of wild vegetables from Western Nepal,” Plants, vol. 8, no. 4, p. 96, 2019. View at: Publisher Site | Google Scholar
  76. N. Phuyal, P. K. Jha, P. P. Raturi, and S. Rajbhandary, “Total phenolic, flavonoid contents, and antioxidant activities of fruit, seed, and bark extracts of Zanthoxylum armatum DC,” The Scientific World Journal, vol. 2020, Article ID e8780704, pp. 1–7, 2020. View at: Publisher Site | Google Scholar
  77. K. Sai, R. Thapa, H. P. Devkota, and K. R. Joshi, “Phytochemical screening, free radical scavenging and α-amylase inhibitory activities of selected medicinal plants from western Nepal,” Medicines (Basel), vol. 6, 2019. View at: Publisher Site | Google Scholar
  78. B. Subba, S. Gaire, and K. Raj Sharma, “Analysis of phyto-constituents, antioxidant, and alpha amylase inhibitory activities of persea americana Mill., Rhododendron arboretum Sm. Rubus ellipticus Sm. from Arghakhanchi district Nepal,” Asian Journal of Pharmaceutical and Clinical Research, vol. 12, no. 1, p. 301, 2019. View at: Publisher Site | Google Scholar
  79. D. J. Newman and G. M. Cragg, “Natural products as sources of new drugs over the 30 years from 1981 to 2010,” Journal of Natural Products, vol. 75, no. 3, pp. 311–335, 2012. View at: Publisher Site | Google Scholar
  80. E. Barone, V. Calabrese, and C. Mancuso, “Ferulic acid and its therapeutic potential as a hormetin for age-related diseases,” Biogerontology, vol. 10, no. 2, pp. 97–108, 2009. View at: Publisher Site | Google Scholar
  81. S. I. Rizvi and N. Mishra, “Anti-oxidant effect of quercetin on type 2 diabetic erythrocytes,” Journal of Food Biochemistry, vol. 33, no. 3, pp. 404–415, 2009. View at: Publisher Site | Google Scholar
  82. B. Kis, S. Avram, I. Z. Pavel et al., “Recent advances regarding the phytochemical and therapeutic uses of populus nigra L. Buds,” Plants, vol. 9, no. 11, p. 1464, 2020. View at: Publisher Site | Google Scholar
  83. F. Mujeeb, P. Bajpai, and N. Pathak, “Phytochemical evaluation, antimicrobial activity, and determination of bioactive components from leaves of aegle marmelos,” Biomed Research International, vol. 2014, 2014. View at: Publisher Site | Google Scholar
  84. K. Balamurugan, A. Nishanthini, and V. R. Mohan, “Antidiabetic and antihyperlipidaemic activity of ethanol extract of Melastoma malabathricum Linn. leaf in alloxan induced diabetic rats,” Asian Pacific Journal of Tropical Biomedicine, vol. 4, pp. S442–S448, 2014. View at: Publisher Site | Google Scholar
  85. T. Tunsaringkarn, A. Rungsiyothin, and N. Ruangrungsi, “α-glucosidase inhibitory activity of water soluble extract from Thai mimosaceous plants,” Journal of Health Research, vol. 1, pp. 54–63, 2009, https://www.tci-thaijo.org/index.php/phjbuu/article/view/45607. View at: Google Scholar
  86. A. K. Keshari, G. Kumar, P. S. Kushwaha et al., “Isolated flavonoids from Ficus racemosa stem bark possess antidiabetic, hypolipidemic and protective effects in albino Wistar rats,” Journal of Ethnopharmacology, vol. 181, pp. 252–262, 2016. View at: Publisher Site | Google Scholar
  87. P. Singh, V. K. Singh, and A. K. Singh, “Molecular docking analysis of candidate compounds derived from medicinal plants with type 2 diabetes mellitus targets,” Bioinformation, vol. 15, no. 3, pp. 179–188, 2019. View at: Publisher Site | Google Scholar
  88. L. R. Fukumoto and G. Mazza, “Assessing antioxidant and prooxidant activities of phenolic compounds†,” Journal of Agricultural and Food Chemistry, vol. 48, no. 8, pp. 3597–3604, 2000. View at: Publisher Site | Google Scholar
  89. A. I. Martinez-Gonzalez, Á. G. Díaz-Sánchez, L. A. d. l. Rosa, C. L. Vargas-Requena, I. Bustos-Jaimes, and a. E. Alvarez-Parrilla, “Polyphenolic compounds and digestive enzymes: in vitro non-covalent interactions,” Molecules, vol. 22, no. 4, p. 669, 2017. View at: Publisher Site | Google Scholar
  90. M. N. Sarian, Q. U. Ahmed, S. Z. Mat So’ad et al., “Antioxidant and antidiabetic effects of flavonoids: a structure-activity relationship based study,” BioMed Research International, vol. 2017, pp. 1–14, 2017. View at: Publisher Site | Google Scholar
  91. A. C. de Camargo, B. T. Favero, M. C. Morzelle et al., “Is chickpea a potential substitute for soybean? phenolic bioactives and potential health benefits,” International Journal of Molecular Sciences, vol. 20, no. 11, p. 2644, 2019. View at: Publisher Site | Google Scholar
  92. A. C. da C. Pinaffi, G. R. Sampaio, M. J. Soares, F. Shahidi, A. C. de Camargo, and E. A. F. S. Torres, “Insoluble-bound polyphenols released from guarana powder: inhibition of alpha-glucosidase and proanthocyanidin profile,” Molecules, vol. 25, no. 3, p. 679, 2020. View at: Publisher Site | Google Scholar
  93. P. Deepa, K. Sowndhararajan, S. Kim, and S. J. Park, “A role of Ficus species in the management of diabetes mellitus: a review,” Journal of Ethnopharmacology, vol. 215, pp. 210–232, 2018. View at: Publisher Site | Google Scholar
  94. M. Dashtdar, M. R. Dashtdar, B. Dashtdar, M. k. shirazi, and S. A. Khan, “In-vitro, anti-bacterial activities of aqueous extracts of Acacia catechu (L.F.)Willd, castanea sativa, ephedra sinica stapf and shilajita mumiyo against gram positive and gram negative bacteria,” Journal of Pharmacopuncture, vol. 16, no. 2, pp. 15–22, 2013. View at: Publisher Site | Google Scholar
  95. S. Joshi, Y. P. Subedi, and S. K. Paudel, “Antibacterial and antifungal activity of heartwood of acacia catechu of Nepal,” Journal of Nepal Chemical Society, vol. 27, pp. 94–99, 2011. View at: Publisher Site | Google Scholar
  96. J. D. Patel, V. Kumar, and S. A. Bhatt, “Antimicrobial screening and phytochemical analysis of the resin part of Acacia catechu,” Pharmaceutical Biology, vol. 47, no. 1, pp. 34–37, 2009. View at: Publisher Site | Google Scholar
  97. M. L. Saini, R. Saini, S. Roy, and A. Kumar, “Comparative pharmacognostical and antimicrobial studies of Acacia species (Mimosaceae),” Journal of Medicinal Plants Research, vol. 2, pp. 378–386, 2008. View at: Google Scholar
  98. S. B. Chandrasekar, M. Bhanumathy, A. Pawar, and T. Somasundaram, “Phytopharmacology of Ficus religiosa,” Pharmacognosy Reviews, vol. 4, no. 8, pp. 195–199, 2010. View at: Publisher Site | Google Scholar
  99. Z. A. A. Alnajar, M. A. Abdulla, H. M. Ali, M. A. Alshawsh, and A. H. A. Hadi, “Acute toxicity evaluation, antibacterial, antioxidant and immunomodulatory effects of melastoma malabathricum,” Molecules, vol. 17, no. 3, pp. 3547–3559, 2012. View at: Publisher Site | Google Scholar
  100. D. Biswas, B. Mahalakshmi, B. Samelu, M. Devadas, and S. V. S. Kumar, “Antimicrobial activity of ethanol extracts and isolated fractions shorea robusta gaertn f and dipterocarpus turbinatus gaertn f,” Pharmacognosy Communications, vol. 10, no. 2, pp. 102–107, 2020. View at: Publisher Site | Google Scholar
  101. I. N. Ismail, “Antibacterial activity of flower, leave and stem extract of melastoma decemfidum,” International Journal of Life Sciences Biotechnology and Pharma Research, vol. 6, p. 5, 2017, http://www.ijlbpr.com/uploadfile/2017/0706/20170706020046974.pdf. View at: Google Scholar
  102. A. Aleem and H. Kabir, “Review on swertia chirata as traditional uses to its pyhtochemistry and phrmacological activity,” Journal of Drug Delivery and Therapeutics, vol. 8, no. 5-s, pp. 73–78, 2018. View at: Publisher Site | Google Scholar
  103. V. Kumar and J. Van Staden, “A review of swertia chirayita (gentianaceae) as a traditional medicinal plant,” Frontiers in Pharmacology, vol. 6, 2016. View at: Publisher Site | Google Scholar
  104. M. M. Cowan, “Plant products as antimicrobial agents,” Clinical Microbiology Reviews, vol. 12, no. 4, pp. 564–582, 1999, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC88925/. View at: Publisher Site | Google Scholar
  105. L. Boulekbache-Makhlouf, S. Slimani, and K. Madani, “Total phenolic content, antioxidant and antibacterial activities of fruits of Eucalyptus globulus cultivated in Algeria,” Industrial Crops and Products, vol. 41, pp. 85–89, 2013. View at: Publisher Site | Google Scholar
  106. M. A. Hye, M. A. Taher, M. Y. Ali, M. U. Ali, and S. Zaman, “Isolation of (+)-catechin from acacia catechu (cutch tree) by a convenient method,” Journal of Scientific Research, vol. 1, no. 2, pp. 300–305, 2009. View at: Publisher Site | Google Scholar
  107. T. A. Ibrahim, R. A. E. Dib, H. M. Al-Youssef, and M. Amina, “Chemical composition and antimicrobial and cytotoxic activities of antidesm abunius L,” Pakistan Journal of Pharmaceutical Sciences, vol. 11, 2019. View at: Google Scholar
  108. D. Shen, Q. Wu, M. Wang, Y. Yang, E. J. Lavoie, and J. E. Simon, “Determination of the predominant catechins in acacia catechu by liquid chromatography/electrospray ionization−mass spectrometry,” Journal of Agricultural and Food Chemistry, vol. 54, no. 9, pp. 3219–3224, 2006. View at: Publisher Site | Google Scholar
  109. Y. Wang, P. d. B. Harrington, and P. Chen, “Quantitative analysis of proanthocyanidins in cocoa using cysteamine-induced thiolysis and reversed-phase UPLC,” Analytical and Bioanalytical Chemistry, vol. 412, no. 18, pp. 4343–4352, 2020. View at: Publisher Site | Google Scholar
  110. C. Zhan, A. Xiong, D. Shen, L. Yang, and Z. Wang, “Characterization of the principal constituents of danning tablets, a Chinese formula consisting of seven herbs, by an UPLC-DAD-MS/MS approach,” Molecules, vol. 21, no. 5, p. 631, 2016. View at: Publisher Site | Google Scholar
  111. E. C. Bate-Smith and T. C. Whitmore, “Chemistry and taxonomy in the dipterocarpaceae,” Nature, vol. 184, no. 4689, pp. 795-796, 1959. View at: Publisher Site | Google Scholar
  112. J. B. Harborne, “The evolution of flavonoid pigments in plants,” Comparative Phytochemistry, vol. 24, pp. 271–295, 1996. View at: Google Scholar
  113. C. Giorio, E. Moyroud, B. J. Glover, P. C. Skelton, and M. Kalberer, “Direct surface analysis coupled to high-resolution mass spectrometry reveals heterogeneous composition of the cuticle ofhibiscus trionumpetals,” Analytical Chemistry, vol. 87, no. 19, pp. 9900–9907, 2015. View at: Publisher Site | Google Scholar
  114. A. Petsalo, J. Jalonen, and A. Tolonen, “Identification of flavonoids of Rhodiola rosea by liquid chromatography-tandem mass spectrometry,” Journal of Chromatography A, vol. 1112, no. 1-2, pp. 224–231, 2006. View at: Publisher Site | Google Scholar
  115. X. Fu, X.-C. Li, Y.-H. Wang et al., “Flavonol glycosides from the South African medicinal PlantSutherlandia frutescens,” Planta Medica, vol. 76, no. 02, pp. 178–181, 2010. View at: Publisher Site | Google Scholar
  116. W. Wang, J. Dang, Y. Shao et al., “A novel chromatographic separation method for rapid enrichment and isolation of novel flavonoid glycosides from Sphaerophysa salsula,” Journal of Separation Science, vol. 43, no. 21, pp. 4018–4027, 2020. View at: Publisher Site | Google Scholar
  117. A. L. Santos, M. G. Soares, L. S. de Medeiros, M. J. P. Ferreira, and P. Sartorelli, “Identification of flavonoid-3-O-glycosides from leaves of Casearia arborea (Salicaceae) by UHPLC-DAD-ESI-HRMS/MS combined with molecular networking and NMR,” Phytochemical Analysis, vol. 8, 2021. View at: Publisher Site | Google Scholar
  118. N. L. Vuković, M. D. Vukić, G. T. Đelić, M. M. Kacaniova, and M. Cvijović, “The investigation of bioactive secondary metabolites of the methanol extract of eryngium amethystinum,” Kragujevac Journal of Science, vol. 113, pp. 113–129, 2018. View at: Google Scholar
  119. W. Liu, J. Huang, F. Zhang, C. Zhang, R. Li, and Y. Wang, “Comprehensive profiling and characterization of the absorbed components and metabolites in mice serum and tissues following oral administration of qingfei paidu decoction by UHPLC-Q-exactive-Orbitrap HRMS,” 2020. View at: Google Scholar
  120. D. Şöhretoğlu, M. K. Sakar, S. A. Sabuncuoğlu, H. Özgüneş, and O. Sterner, “Antioxidant galloylated flavonoids from Geranium tuberosum L. subsp. tuberosum,” Turkish Journal of Chemistry, vol. 33, pp. 685–692, 2009. View at: Google Scholar
  121. R. E. March and X.-S. Miao, “A fragmentation study of kaempferol using electrospray quadrupole time-of-flight mass spectrometry at high mass resolution,” International Journal of Mass Spectrometry, vol. 231, no. 2-3, pp. 157–167, 2004. View at: Publisher Site | Google Scholar
  122. S. I. Alqasoumi, A. J. Al-Rehaily, and M. S. Abdel-Kader, “Phytochemical and pharmacological study of Ficus cordata growing in Saudi Arabia,” Pakistan Journal of Pharmaceutical Sciences, vol. 27, no. 6, pp. 1841–9, 2014. View at: Google Scholar

Copyright © 2021 Babita Aryal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views1378
Downloads594
Citations

Related articles

No related content is available yet for this article.

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.